FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2045793681> ?p ?o ?g. }

• W2045793681 endingPage "839" @default.
• W2045793681 startingPage "828" @default.
• W2045793681 abstract "Sudden cardiac arrest is a major public heath problem, affecting more than 450,000 individuals annually. Response time and the initiation of cardiopulmonary resuscitation (CPR) remain the most important factors determining successful revival. During resuscitation, sympathomimetics are given to enhance cerebral and coronary perfusion pressures in an attempt to achieve restoration of spontaneous circulation. Epinephrine has been the preferred vasopressor since the inception of advanced cardiac life support, although the lack of definitive evidence regarding its effectiveness has created much controversy surrounding its use, including the optimum dosage. Vasopressin is an alternative vasopressor that, when given at high doses, causes vasoconstriction by directly stimulating smooth muscle V1 receptors. The 2000 American Heart Association (AHA) guidelines commented that vasopressin is a reasonable first-line vasopressor in patients with ventricular fibrillation or pulseless ventricular tachycardia. Since release of those guidelines, additional human studies support an expanded role for vasopressin, whereas other studies cast doubt regarding its efficacy compared with epinephrine. The AHA recently released revised guidelines for CPR and emergency cardiovascular care. The consensus was that vasopressors should remain a part of pulseless sudden cardiac arrest management, with epinephrine 1 mg every 3–5 minutes being the recommended adrenergic of choice. In these revised guidelines, the role of vasopressin expanded beyond previous recommendations, despite the recommendation being downgraded to class indeterminate. The guidelines comment that one dose of vasopressin 40 U may replace the first or second dose of epinephrine in all pulseless sudden cardiac arrest scenarios, including asystole and pulseless electrical activity. A consistent theme with all vasopressors in sudden cardiac arrest is that additional studies are necessary to clearly document greater efficacy compared with no treatment. Further evaluation is warranted to better assess the role of vasopressin in asystolic sudden cardiac arrest, as well as its use with epinephrine, and to determine its optimal timing of administration and potential synergistic effects." @default.
• W2045793681 created "2016-06-24" @default.
• W2045793681 creator A5019635522 @default.
• W2045793681 creator A5089063860 @default.
• W2045793681 date "2006-06-01" @default.
• W2045793681 modified "2023-09-23" @default.
• W2045793681 title "Evolving Role of Vasopressin in the Treatment of Cardiac Arrest" @default.
• W2045793681 cites W1953617848 @default.
• W2045793681 cites W1974786071 @default.
• W2045793681 cites W1977036718 @default.
• W2045793681 cites W1980583127 @default.
• W2045793681 cites W1986215651 @default.
• W2045793681 cites W1997152430 @default.
• W2045793681 cites W2003922776 @default.
• W2045793681 cites W2004758176 @default.
• W2045793681 cites W2005157105 @default.
• W2045793681 cites W2006371326 @default.
• W2045793681 cites W2011319443 @default.
• W2045793681 cites W2014364037 @default.
• W2045793681 cites W2015049171 @default.
• W2045793681 cites W2023037707 @default.
• W2045793681 cites W2026509542 @default.
• W2045793681 cites W2029060271 @default.
• W2045793681 cites W2029868871 @default.
• W2045793681 cites W2033028932 @default.
• W2045793681 cites W2035200928 @default.
• W2045793681 cites W2036935758 @default.
• W2045793681 cites W2049999313 @default.
• W2045793681 cites W2054467344 @default.
• W2045793681 cites W2057635622 @default.
• W2045793681 cites W2057652030 @default.
• W2045793681 cites W2057699879 @default.
• W2045793681 cites W2059672373 @default.
• W2045793681 cites W2060123825 @default.
• W2045793681 cites W2070693224 @default.
• W2045793681 cites W2070939005 @default.
• W2045793681 cites W2073991158 @default.
• W2045793681 cites W2074171621 @default.
• W2045793681 cites W2079993464 @default.
• W2045793681 cites W2080080835 @default.
• W2045793681 cites W2082984833 @default.
• W2045793681 cites W2084921666 @default.
• W2045793681 cites W2087562411 @default.
• W2045793681 cites W2091933273 @default.
• W2045793681 cites W2094525340 @default.
• W2045793681 cites W2095374423 @default.
• W2045793681 cites W2099687485 @default.
• W2045793681 cites W2110944531 @default.
• W2045793681 cites W2113519449 @default.
• W2045793681 cites W2116866503 @default.
• W2045793681 cites W2120866167 @default.
• W2045793681 cites W2128989245 @default.
• W2045793681 cites W2132095149 @default.
• W2045793681 cites W2134904191 @default.
• W2045793681 cites W2141695400 @default.
• W2045793681 cites W2146635220 @default.
• W2045793681 cites W2152966419 @default.
• W2045793681 cites W2161604579 @default.
• W2045793681 cites W2318257564 @default.
• W2045793681 cites W2324258168 @default.
• W2045793681 cites W2330246420 @default.
• W2045793681 cites W2337485397 @default.
• W2045793681 cites W4234545731 @default.
• W2045793681 cites W4236836350 @default.
• W2045793681 cites W4241697932 @default.
• W2045793681 cites W4242549075 @default.
• W2045793681 cites W4242823687 @default.
• W2045793681 doi "https://doi.org/10.1592/phco.26.6.828" @default.
• W2045793681 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16716136" @default.
• W2045793681 hasPublicationYear "2006" @default.
• W2045793681 type Work @default.
• W2045793681 sameAs 2045793681 @default.
• W2045793681 citedByCount "13" @default.
• W2045793681 countsByYear W20457936812014 @default.
• W2045793681 countsByYear W20457936812015 @default.
• W2045793681 countsByYear W20457936812018 @default.
• W2045793681 countsByYear W20457936812021 @default.
• W2045793681 countsByYear W20457936812022 @default.
• W2045793681 crossrefType "journal-article" @default.
• W2045793681 hasAuthorship W2045793681A5019635522 @default.
• W2045793681 hasAuthorship W2045793681A5089063860 @default.
• W2045793681 hasConcept C126322002 @default.
• W2045793681 hasConcept C164705383 @default.
• W2045793681 hasConcept C177713679 @default.
• W2045793681 hasConcept C2775859304 @default.
• W2045793681 hasConcept C2775935837 @default.
• W2045793681 hasConcept C2776370428 @default.
• W2045793681 hasConcept C2776818218 @default.
• W2045793681 hasConcept C2777055891 @default.
• W2045793681 hasConcept C2777205947 @default.
• W2045793681 hasConcept C2777862461 @default.
• W2045793681 hasConcept C2778165595 @default.
• W2045793681 hasConcept C2778496132 @default.
• W2045793681 hasConcept C2778550298 @default.
• W2045793681 hasConcept C2781005686 @default.
• W2045793681 hasConcept C42219234 @default.
• W2045793681 hasConcept C71924100 @default.
• W2045793681 hasConceptScore W2045793681C126322002 @default.

• next